x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001146
| Product Information | |
|---|---|
| Product Name | Monkey IL-1α ELISA Kit |
| Species | Monkey |
| Description | Monkey IL-1a ELISA Kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of IL-1a protein in edta plasma, hep plasma, serum, and cit plasma. It uses our proprietary ELISA technology. Quantitate Monkey IL-1a with 12.21 pg/mL sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
| Sample Types | Serum, Hep Plasma, Edta Plasma, Cit Plasma |
| Detection Range | 15.63 pg/mL - 1000 pg/mL |
| Sensitivity | 12.21 pg/mL |
| Target Information | |
|---|---|
| Target Name | IL1A |
| UniProt No. | P01583 |
| Gene ID | 3552 |
| Target Description | Produced by activated macrophages, IL-1 stimulates thymocyte proliferation by inducing IL-2 release, B-cell maturation and proliferation, and fibroblast growth factor activity. IL-1 proteins are involved in the inflammatory response, being identified as endogenous pyrogens, and are reported to stimulate the release of prostaglandin and collagenase from synovial cells. |
| Alternative Names | BAF; FAF; Hematopoietin 1; Hematopoietin-1; IL 1α; IL 1A; IL-1α; Il-1a; IL1; IL1α; IL1A; IL1A_HUMAN; IL1F1; Interleukin 1α; Interleukin-1α; Interleukin1α; LAF; LEM; Preinterleukin 1α; Pro interleukin 1α |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
